Form 4: Aspira Women's Health Director Exercises Restricted Stock Units
SEC Form 4
Jannie Prestridge Herchuk, a director at Aspira Women's Health Inc., converted 8,438 restricted stock units into common stock on September 30, 2024.
Summary
- On September 30, 2024, Jannie Prestridge Herchuk, a director of Aspira Women's Health Inc., converted 8,438 restricted stock units (RSUs) into common stock.
- The RSUs were part of a grant of 33,750 RSUs awarded on August 22, 2024, with 8,438 vesting on September 30, 2024.
- Following the transaction, Herchuk directly owns 57,190 shares of common stock and 25,312 restricted stock units.
Sentiment
Score: 5
Explanation: This is a neutral event, simply a reporting of stock options vesting. It doesn't inherently indicate positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, providing transparency to investors regarding the actions of company directors.
Stakeholder Impact
- The transaction has a minor dilutive effect on existing shareholders due to the issuance of new shares.
Key Dates
| Date | Description |
|---|---|
| 08/22/2024 | Reporting person was granted 33,750 RSUs. |
| 08/26/2024 | Previous Form 4 filed with the SEC reporting the grant of RSUs. |
| 09/30/2024 | 8,438 RSUs vested and were converted into common stock. |
| 10/02/2024 | Date of signature on the Form 4. |
Keywords
Aspira Women's Health, Director, Insider Trading, Form 4, Restricted Stock Units, Common Stock, AWH, Vesting
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.